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Abstract Despite that cognitive impairment is a known
early feature present in multiple sclerosis (MS) patients,
the biological substrate of cognitive deficits in MS
remains elusive. In this study, we assessed whether T1
relaxometry, as obtained in clinically acceptable scan
times by the recent Magnetization Prepared 2 Rapid
Acquisition Gradient Echoes (MP2RAGE) sequence, may
help identifying the structural correlate of cognitive defi-
cits in relapsing-remitting MS patients (RRMS). Twenty-
nine healthy controls (HC) and forty-nine RRMS patients
underwent high-resolution 3T magnetic resonance imag-
ing to obtain optimal cortical lesion (CL) and white matter
lesion (WML) count/volume and T1 relaxation times. T1
z scores were then obtained between T1 relaxation times
in lesion and the corresponding HC tissue. Patient cog-
nitive performance was tested using the Brief Repeatable
Battery of Neuro-psychological Tests. Multivariate ana-
lysis was applied to assess the contribution of MRI vari-
ables (T1 z scores, lesion count/volume) to cognition in
patients and Bonferroni correction was applied for multi-
ple comparison. T1 z scores were higher in WML
(p \ 0.001) and CL-I (p \ 0.01) than in the corresponding
normal-appearing tissue in patients, indicating relative
microstructural loss. (1) T1 z scores in CL-I (p = 0.01)
and the number of CL-II (p = 0.04) were predictors of
long-term memory; (2) T1 z scores in CL-I (b = 0.3;
p = 0.03) were independent determinants of long-term
memory storage, and (3) lesion volume did not signifi-
cantly influenced cognitive performances in patients. Our
study supports evidence that T1 relaxometry from
MP2RAGE provides information about microstructural
properties in CL and WML and improves correlation with
cognition in RRMS patients, compared to conventional
measures of disease burden.
Keywords High field MRI  T1 relaxation time  Multiple
sclerosis  Cognitive impairment  Cortical pathology
Introduction
Cognitive impairment affects approximately 40–70 % of
the multiple sclerosis (MS) patients [1, 2]. Frequently
affected functions include attention, information process-
ing speed, executive functioning, and long-term memory
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[3]. Among these, information processing speed appears to
be one the most common cognitive deficits in early MS [4].
Conventional magnetic resonance imaging (MRI) has
been extensively exploited to investigate cognitive dys-
function in MS [3, 5, 6]. Nevertheless, correlations
between the extent of white matter (WM) abnormalities
detected on conventional brain MRI and cognitive
impairment are generally low [7–11]. Likewise, measures
of whole-brain atrophy showed only moderate correlations
with cognitive dysfunction [3, 6]. Recently, the number of
cortical lesions (CLs), detected with Double Inversion
Recovery [DIR] sequence [12], has shown higher corre-
lations with cognitive impairment than the number of
WM plaques [8, 13, 14]. Cortical atrophy has also been
reported to have a higher impact than whole-brain atrophy
on cognitive impairment [15], and recent ultra-high-field
MRI investigations provided evidence that a specific
subtype of cortical lesions (mixed white matter-grey
matter, type I) are major determinants of neuropsycho-
logical performance in MS patients [16].
Nevertheless, most of the cited studies applied tech-
niques that are not compatible with clinical practice due
to important artefacts (DIR) [12], long measurement
times or magnetic fields that are not homologated for
clinical routine (7T). In addition, most published studies
focused on patients with late RRMS or on secondary
progressive MS patients with moderate to severe cogni-
tive dysfunction.
T1 quantitative measures provide more direct measures
of the microstructural lesions and are paraclinical used as
markers of subtle microstructural damage. T1 relaxation
times help distinguish lesions from normal-appearing (NA)
tissue in patients and healthy tissue in controls [17–19].
Long T1 values suggest loss of tissue structure or water
accumulation and short T1 values correspond to patho-
logical processes such as accumulation of methemoglobin,
proteinaceous material, lipids, free radicals, paramagnetic
metals (non-heme iron) and remyelination [20]. Therefore,
T1 measurements might provide information to increase
correlation between MRI measures of disease states and
cognitive deficits. Whole-brain T1 relaxometry can be
obtained in clinically acceptable scan-times using the
MP2RAGE sequence [21], which has been recently shown
to be nearly as sensitive as DIR for cortical lesion detection
and more sensitive than 3D FLAIR for WM lesion detec-
tion [22].
In this study, we aimed at assessing the clinical value of
MP2RAGE T1 relaxometry at early stages of MS. Spe-
cifically, we investigated whether quantitative T1 measures
of tissue lesion alterations improve correlations with subtle
cognitive symptoms in a cohort of RRMS patients with less
than 6 years of disease duration.
Methods
Subject population
Forty-nine patients (14 males and 35 females) with early
(disease duration \6 years) RRMS according to the
McDonald criteria [23, 24] were enrolled in the study (age
34.2 ± 8.8 years, mean ± standard deviation; educational
level 15.2 ± 2.9 years; disease duration 2.9 ± 1.9 years;
expanded disability status scale EDSS 1.6 ± 0.3). Patients
with a diagnosis of major depression or other psychiatric
disorders according to the DSM-IV criteria were not
considered.
The healthy control (HC) group consisted of twenty-
nine healthy volunteers (8 males and 21 females; mean age:
32.3 ± 8.3 years; mean educational level 16.7 ± 3.2
years) with no history of alcohol or drug abuse, major
psychiatric disorders (major depression, psychosis,
untreated bipolar disorders), head trauma, other neurolog-
ical disorders or systemic illness.
All participants underwent a neuropsychological exam-
ination and brain MRI. The study was approved by the
local Ethics Committee and all subjects gave informed
consent for their participation.
Neuropsychological assessment
All participants underwent the Brief Repeatable Battery of
Neuropsychological Tests (BRB-N) [25]. In short, the
BRB-N is composed of the following tests:
1. The Selective Reminding Test (SRT) measures verbal
learning and delayed recall through presentation of a
list of 12 words and six consecutive learning trials. The
SRT allows distinguishing between retrieval from
short-term and long-term memory and also examines
the consistency of retrieval from long-term memory.
This study used three indices: the long-term storage
(LTS) defined as any word recalled on two consecutive
trials, the consistent long-term retrieval (CLTR)
defined as any word in LTS consistently recalled on
all subsequent trials and the Delayed recall (SRTD)
representing the total number of words recalled after a
20-min delay.
2. The 10/36 spatial recall test (SPART) assesses visu-
ospatial learning and recall by recreating the pattern of
10 checkers on a 6 9 6 checkerboard viewed for 10 s.
3. The symbol digit modalities test (SDMT) measures
sustained attention and processing speed by requiring
the subject to associate symbols with numbers and
quickly orally generating the number when shown the
symbol during 90 s.
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4. The paced auditory serial addition task (PASAT)
evaluates sustained attention, auditory information
processing speed and working memory and is mea-
sured by asking the patient to add each number to the
preceding number with additional numbers presented
every 3 s;
5. The word list generation (WLG) measures semantic
verbal fluency, evaluating the spontaneous production
of words from a specific semantic category for 60 s.
The complete set of neuropsychological tests is
presented in Table 1.
Mood symptoms and fatigue were quantified using the
Hospital Anxiety and Depression scale (HAD) [26] and the
Fatigue Scale for Motor and Cognitive functions (FSMC)
[27], respectively.
MRI data acquisition
Within 2 weeks from neuropsychological assessment,
participants underwent brain MRI at 3T (Magnetom Trio a
Tim System, Siemens Healthcare, Germany) using a
commercial 32-channel head coil. The acquisition protocol
was optimized to maximise lesion detection in WM and
GM as well as in the cerebrum and the cerebellum.
The imaging protocol included the magnetization-pre-
pared rapid gradient echo (MPRAGE), the double-inver-
sion recovery (DIR) [12], the two inversion-contrast
magnetization-prepared rapid gradient echo (MP2RAGE)
[21] and the 3-dimensional fluid attenuated inversion
recovery (3D FLAIR) sequences [28]. For sequence
parameter details see Table 2.
Table 1 Neuropsychological tests
BRB-N Tested cognitive functions
SRT-CLTR Verbal learning and memory: consistency of retrieval from long-term memory component
SRT-D Verbal learning and memory: delayed recall component
SRT-LTS Verbal learning and memory: long-term storage component
SDMT Processing speed and working memory
PASAT Sustained attention and information processing speed
SPART Visuospatial learning and recall
SPART-D Visuospatial learning and delayed recall
WLG Semantic verbal fuency test
BRB-N brief repeatable battery of neuropsychological tests, SRT-CLTR selective reminding test-consistent long-term retrieval, SRT-D selective
reminding test-delayed recall, SRT-LTS selective reminding test-long-term storage, SDMT symbol digit modalities test, PASAT paced auditory
serial addition test at 3 s, SPART 10/36 spatial recall test, SPART-D 10/36 spatial recall test-delayed, WLG word list generation
Table 2 MRI sequences
parameters
Parameters of all employed
imaging sequences. All 3D
contrasts were acquired with the
same spatial resolution
3DFLAIR 3-dimensional fluid
attenuated inversion recovery,
MP2RAGE two inversion-
contrast magnetization-prepared
rapid gradient echo, DIR
double-inversion recover, TE
echo time, TR repetition time
a Optimized variable flip angle
(VFL) pattern over the readout
train
3D FLAIR MP-RAGE MP2RAGE DIR
Sequence parameters
Acquisition 3D 3D 3D 3D
Resolution 1 9 1 9 1.2 mm3 1 9 1 9 1.2 mm3 1 9 1 9 1.2 mm3 1.1 9 1 9 1.2 mm3
Orientation/readout Sagittal/A  P
Matrix size 240 9 256 256 9 256 240 9 256 240 9 256
Slice/partitions 176 160 176 160
Acquisition time 6 min 27 s 5 min 12 8 min 22 s 12 min 52 s
No patients/controls
scans
49/29 49/29 49/29 49/29
Acceleration factor 2 2 3 2
TE (ms) 394 2.98 2.89 218
Inversion
time(s) (ms)
1,800 900 700/2,500 3,650
Flip angle(s) () VFLa 9 4 VFLa
Echo/readout train
length (ms)
835 1,162 1,162 640
TR (ms) 5,000 2,300 5,000 10,000
Bandwidth
(Hz/pixels)
781 240 240 651
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Post-processing
In order to maximize lesion detection (number and vol-
ume), a certified neurologist and a certified neuroradiolo-
gist identified brain lesions by consensus in DIR,
MP2RAGE uniform and 3DFLAIR images separately, as
previously reported [22]. Subsequently, the lesions were
manually contoured and assigned to one of the following
classes: GM (cortical lesion type II, CL-II), mixed cerebral
GM/WM (cortical lesion type I, CL-I) and WM (white
matter). The resulting masks were confirmed a second time
and, if necessary, corrected by a study physician.
The imaging volume and lesion masks were patient-wise
co-registered to a common image space using an in-house
registration software. Subsequently, a single-set union-
mask was created per patient containing all lesions from all
contrasts with their maximum spatial extent [22]. The
union mask was applied to the T1-maps from the
MP2RAGE. Lesion volumes were obtained using an in-
house software [29]. Cortical and WM lesion number,
volume and T1 relaxation times were evaluated for each of
the union mask sets.
For each patient, T1 z scores of mean relaxation times
were calculated for each cortical and WM lesion as follows:
z ¼ x l
r
;
where x is the T1 mean relaxation time for each patient
lesion, l is the T1 mean relaxation time for each HC in the
corresponding tissue (cortical GM and WM) and r is the
standard deviation of the T1 relaxation time in HC within
the same tissue region. Cortical GM and WM regions of
interest in the HC were derived from the MPRAGE image
using in-house software based on variational expectation–
maximization tissue classification [30].
T1 z score measures of T1 relaxation times were pre-
ferred to T1 relaxation times in order to be able to perform
correlation analysis in the whole cohort of patients,
including subjects lacking lesions in a specific location (i.e.
CL-I and CL-II).
Statistical analysis
Kruskal–Wallis test was used to compare demographic,
clinical and behavioural findings between patients and
controls. A Box–Cox transformation was applied to all
demographic, clinical and MRI variables (lesion number
and volume) to obtain data normalization prior to analysis.
The same test was also applied to compare T1 z scores
in lesions and corresponding normal-appearing tissue.
A general linear model regression was applied to evaluate
the correlation between cognitive scores and MRI scores (T1
z scores, lesion number and volume) as well as covariates
(age, gender and education) and behavioural score (HAD) as
predictors. Backward stepwise analyses were conducted
with the Wald criterion using p = 0.05 for entry level and
p = 0.10 for removal. Bonferroni correction was applied for
multiple comparison. The significant variables were identi-
fied with p value \0.05. All statistical analysis was per-
formed using MATLAB R2013a Statistical Toolbox.
Results
Clinical and neuropsychological results
Patients did not differ from HCs for gender (p = 0.9) and
age (p = 0.12). However, RRMS patients had slightly
lower education than controls (p = 0.02, mean education
level of patients = 15.2 years and controls = 16.7 years).
Results of cognitive tests are reported in Table 3.
Patients showed on average significantly lower scores on
measures of sustained attention and working memory
(PASAT, p value = 0.01).
On the behavioural questionnaires, RRMS patients and
controls had comparable scores on the HAD anxiety
scale (p = 0.19) but significantly different scores on the
HAD depression scale (p = 0.006). Moreover, patients
showed higher scores of fatigue on the total FSMC score
(p \ 0.001), both on the physical dimension of the scale
(p = 0.001) and on its cognitive dimension (p \ 0.001).
Cortical and subcortical lesion counts and T1 relaxation
times/z scores
Lesion counts in patients and in HCs are presented in
Table 4. All early RRMS patients showed cortical lesions
Table 3 Cognitive test results in RRMS patients and HCs
Cognitive tests RRMS patients (n = 49) HC (n = 29) p value
SRT-LTS 62.5 ± 6.82 64.5 ± 6.5 0.08
SRT-CLTR 56.6 ± 11.1 59.9 ± 9.7 0.22
SRT-D 11.2 ± 1.14 11.5 ± 0.9 0.08
SPART 23.4 ± 4.3 23.3 ± 4.6 0.96
SPART-D 8.6 ± 2.05 8.6 ± 1.8 0.66
SDMT 56.9 ± 9.56 59.6 ± 11.4 0.23
PASAT 46.8 ± 10.8 51.9 ± 10.5 0.01
WLG 27.7 ± 5.3 28.7 ± 6.9 0.18
Bold value corresponds to p value \0.05
SRT-LTS selective reminding test-long-term storage, SRT-CLTR
selective reminding test-consistent long-term retrieval, SRT-D selec-
tive reminding test-delayed recall, SDMT symbol digit modalities test,
PASAT paced auditory serial addition test at 3 s, SPART 10/36 spatial
recall test, SPART-D 10/36 spatial recall test-delayed, np number of
patients, nc number of controls, WLG word list generation
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(CLs), whereas no CLs were observed in HCs. The
majority of CL in patients consisted of type I lesions
(Table 4). The rest of the CLs were type II (intra-cortical
lesions). No type III/IV lesions were detected.
Lesion z scores are reported in Table 4. Except for the pure
cortical (CL-II) lesions, T1 z scores were consistently higher in
lesions compared to the corresponding normal-appearing tissue
in patients (WM lesions: p\0.001, CL-I: p\0.01 Fig. 1).
Table 4 Number of lesions, volume and T1 z scores in HCs and in RRMS patients
Lesion type Lesions in RRMS patients (no.) Lesion volume in RRMS patients (mm3) T1 z scores in RRMS patients
Median Max Min Median Max Min Median Max Min
WMLs 32 140 3 2,449 12,367 58 11.14 20.49 -0.42
CLs II 0 6 0 0 278.4 0 0.00 15.04 -7.58
CLs I 3 31.5 0 174 2,707.2 0 2.31 15.92 -7.82
Lesion type Lesions in HC (no.) Lesion volume in HC (mm3)
Median Max Min Median Max Min
WMLs 1 11 0 11.4 387.6 0
CLs II 0 0 0 0 0 0
CLs I 0 1 0 0 38.4 0
Median median value, Max maximum value, Min minimum value, WMLs white matter lesions, CLs I mixed cortical lesions, CLs II grey matter
cortical lesions, HC healthy controls
WMLs CLs II CLs I
lesion tissue 10.27 2.22 3.39
normal-appearing tissue -0.11 -0.68 -0.46
10.27
2.22
3.39
-0.11
-0.68 -0.46
-2.00
0.00
2.00
4.00
6.00
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Fig. 1 T1 z scores (mean) in lesions and normal appearing tissue in
RRMS patients. WMLs white matter lesions, CLs II grey matter
cortical lesions, CLs I mixed cortical lesions, NS not significant. WM
and CLI lesions show significantly higher T1 z scores compared to
corresponding normal appearing brain tissue in patients. T1 z scores
in pure cortical lesions (CLs II) did not significantly differ from
normal-appearing tissue in patients
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Multiple regression analysis
The results of multiple regression analysis are reported in
Table 5.
Consistent long-term memory retrieval in SRT was sig-
nificantly dependent on gender (b = 0.3; p = 0.03), T1
z scores in CL-I (b = 0.4; p = 0.01) and CL-II lesions
number (b = -0.3; p = 0.04) (r2 = 0.3; F = 4.2;
p = 0.02 corrected). Education (b = 0.3; p = 0.02), HAD
(b = -0.3; p = 0.03) and T1 z scores in CL-I (b = 0.3;
p = 0.03) were found to be independent predictors of Long-
Term Storage component in SRT (r2 = 0.3; F = 4.1;
p = 0.04 corrected).
Education (b = 0.5; p = 0.0005) and HAD (b = -0.3;
p = 0.02) appeared to be independent predictors of sus-
tained attention and working memory (PASAT), whereas
T1 z scores (b = -0.3; p = 0.06) in WM lesions failed to
reach significance (b = -0.3; p = 0.06) (r2 = 0.3;
F = 7.0; p = 0.004 corrected). Gender (b = 0.41;
p = 0.003) and education (b = 0.007; p \ 0.01) were
independent predictors of semantic verbal fluency
(r2 = 0.3; F = 7.8; p = 0.01 corrected).
Discussion
In this study, we show that T1-based microstructural
characteristics of cortical lesions, as measured by
MP2RAGE, improve clinical–radiological correlations
with cognitive performances in early MS, compared to
conventional measures (lesion number and volume).
MP2RAGE is a self-bias-corrected sequence that supports
with T1-weighted images of high anatomical quality as well
as high-resolution T1 relaxometry in a clinically compatible
scan-time [21]. Recently, we showed that MP2RAGE uni-
form images provide higher sensitivity to lesion count than
standard MPRAGE and FLAIR sequences and are nearly as
sensitive as DIR for cortical lesion detection [22].
T1 relaxometry measurements, as provided by
MP2RAGE, are globally influenced by pathological chan-
ges of different severity, such as demyelination, gliosis,
inflammation, axonal injury and axonal loss [31–33]. In
acute MS lesions, there is first a T1 prolongation due to
acute oedema, rapidly followed by T1 shortening; in
chronic plaques, T1 relaxation times are variable, indicat-
ing pathological heterogeneity [15]. T1 relaxometry has
been exploited to assess the degree of tissue alteration in
different MS subtypes [18, 34–36] and our group previ-
ously reported that, in early RRMS, MP2RAGE T1
relaxation times are longer in CL-I and WM lesions com-
pared to healthy control tissue [22]. Moreover, quantitative
T1 measurements were shown to moderately correlate with
global disability (i.e. EDSS) [18, 37] and MS Functional
composite (MSFC) scores [38].
In this work, we aimed at assessing whether the infor-
mation provided by MP2RAGE relaxometry improves the
correlation between MRI markers of early MS disease and
cognition.
We studied a cohort of RRMS patients with less than
6 years of disease duration, who benefitted from a com-
plete neurocognitive examination. Patients exhibited mild
cognitive deficits in sustained attention and working
memory (PASAT), which is in line with previous studies at
early MS stages [2–4, 9, 39–41].
In order to assess the contribution of T1-based measures
of tissue integrity to cognitive performances in patients, we
computed T1 relaxation times z scores between lesions/NA
tissue in patients and corresponding healthy control tissue.
T1 z scores in CL-I and WM lesions were significantly
higher than corresponding T1 z scores in patients NA tis-
sue, indicating relative tissue loss. Furthermore, T1 z scores
in CL-I lesions were major determinants of both long-term
memory retrieval and storage (SRT-CLTR and SRT-LTS),
whereas the number of CL-II contributed only to memory
retrieval.
Lower verbal memory performances were related to
higher T1 z scores in CL-I lesions (positive correlation
coefficient between SRT-CLRT and CL-I T1 z scores),
suggesting that the higher the focal tissue loss the more
important the deficits. On the other hand, the number of
CL-II was a negative predictor of the SRT-CLRT, sig-
nifying that a higher number of pure cortical lesions is
concomitant with less important memory retrieval defi-
cits. This finding, at a first glance counterintuitive, might
suggests that a certain threshold of GM damage is nec-
essary to activate compensatory mechanisms for retrieval
memory like it was previously observed in the motor
cortex [40] and in the working memory system [9].
Our results confirm a recent 7T MRI study reporting that
the number of CL-I was a predictor of cognitive performance
in advanced MS [16] and extend it to early disease stages.
In addition, our work provides evidence that the degree
of cortical and juxta-cortical damage is closely related to
the presence of memory deficits and suggests potential
pathophysiological mechanisms leading to cognitive dys-
function in early MS.
In summary, we show that T1 relaxation times obtained
from MP2RAGE provide new biomarkers of cognitive
impairment in early MS. Further studies should assess the
prognostic value and sensitivity to therapy of these
measurements.
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